Circular 577 of 15/02/2011 reminds the marketing authorization or registration holders of all the legal obligations as regards communication to the FAMHP of the information concerning the marketing status of their medicinal products.
The FAMHP notably insists on the legal obligation to communicate to her any information concerning a temporary cessation of marketing of a medicinal product.
The cases of unavailable medicinal products that could be a problem for public health or for certain patients will be released on the website of the FAMHP.
Circular 577 concerning legal obligations and practical measures as regards information on the marketing status of the authorised medicines.
Template to fill in to notify the FAMHP of any temporary unavailability of a medicinal product.